Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid. 1999

H Ahman, and H Käyhty, and A Vuorela, and O Leroy, and J Eskola
National Public Health Institute, Helsinki, Finland.

Three injections of tetravalent pneumococcal polysaccharide-tetanus toxoid conjugate vaccine (PncT) were given to infants at 2, 4 and 6 months of age simultaneously with diphtheria-tetanus-pertussis and Haemophilus influenzae type b-tetanus toxoid conjugate vaccines. Three doses (1, 3 or 10 microg) of polysaccharides were used. Children were boosted with unconjugated polysaccharide vaccine at 14 months of age. No dose dependency was seen after primary immunization. However, booster response to three vaccine serotypes was highest in the group primed with the lowest dose of conjugate vaccine. As the magnitude of the response to booster may be related to the number of polysaccharide-specific memory B cells, we hypothesize that the 10 microg dose of the tetravalent conjugate vaccine is too high for optimal induction of immunologic memory.

UI MeSH Term Description Entries
D007117 Immunization, Secondary Any immunization following a primary immunization and involving exposure to the same or a closely related antigen. Immunization, Booster,Revaccination,Secondary Immunization,Booster Immunization,Booster Immunizations,Immunizations, Booster,Immunizations, Secondary,Revaccinations,Secondary Immunizations
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D007223 Infant A child between 1 and 23 months of age. Infants
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D013296 Streptococcus pneumoniae A gram-positive organism found in the upper respiratory tract, inflammatory exudates, and various body fluids of normal and/or diseased humans and, rarely, domestic animals. Diplococcus pneumoniae,Pneumococcus
D013745 Tetanus Toxoid Tetanus Vaccine,Toxoid, Tetanus,Vaccine, Tetanus
D018074 Vaccines, Conjugate Semisynthetic vaccines consisting of polysaccharide antigens from microorganisms attached to protein carrier molecules. The carrier protein is recognized by macrophages and T-cells thus enhancing immunity. Conjugate vaccines induce antibody formation in people not responsive to polysaccharide alone, induce higher levels of antibody, and show a booster response on repeated injection. Conjugate Vaccine,Conjugate Vaccines,Vaccine, Conjugate

Related Publications

H Ahman, and H Käyhty, and A Vuorela, and O Leroy, and J Eskola
December 1994, Leukemia & lymphoma,
H Ahman, and H Käyhty, and A Vuorela, and O Leroy, and J Eskola
December 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
H Ahman, and H Käyhty, and A Vuorela, and O Leroy, and J Eskola
December 2001, Infection and immunity,
H Ahman, and H Käyhty, and A Vuorela, and O Leroy, and J Eskola
June 1996, The Pediatric infectious disease journal,
H Ahman, and H Käyhty, and A Vuorela, and O Leroy, and J Eskola
April 2002, The Pediatric infectious disease journal,
H Ahman, and H Käyhty, and A Vuorela, and O Leroy, and J Eskola
July 1997, The Pediatric infectious disease journal,
H Ahman, and H Käyhty, and A Vuorela, and O Leroy, and J Eskola
April 1955, The Medical journal of Australia,
H Ahman, and H Käyhty, and A Vuorela, and O Leroy, and J Eskola
December 1980, The Indian journal of medical research,
H Ahman, and H Käyhty, and A Vuorela, and O Leroy, and J Eskola
December 2004, Vaccine,
H Ahman, and H Käyhty, and A Vuorela, and O Leroy, and J Eskola
February 1980, The American journal of clinical nutrition,
Copied contents to your clipboard!